Bioquell can improve outcomes and increase savings by reducing Healthcare Associated Infection in Intensive Care Units.
Intensive Care Units are characterized by time pressures and a high proportion of patients vulnerable to HAIs, which cause increased morbidity and length of stay. Reducing length of stay is a key target for most hospitals, given the increasing pressure on hospital beds and the significant costs associated with beds being ‘blocked’.
In order to reduce the risk of these patients becoming infected, and ultimately reduce HAI rates, the hospital is able to deploy Bioquell engineers to decontaminate rooms on either a preventative or reactive basis.
Can you operate in a sensitive environment?
Yes, Bioquell engineers have extensive experience in operating with care and discretion in sensitive hospital environments?
Do you have efficacy over Aspergillus?
Yes, a report from the Health Protection Agency demonstrates the efficacy of Bioquell’s HPV system against Aspergillus (Cabinet bio-decontamination trial. March 1995. Health Protection Agency (previously Centre for Applied Microbiology and Research), Porton Down UK. 1995.).